The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Altergon competitive analysis

Loading summary...

Latest patents of Altergon opposed by its competitors

Explore Altergon's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3056187
Aug 30, 2023Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T41
EP2034956
Jun 28, 2023Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic Cystitis1
EP3528847
Jul 22, 2020High-Stability Packaged Solutions Of T4 Thyroid Hormone1

Latest PTAB cases involving Altergon

Discover the latest PTAB cases involving Altergon, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Altergon with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALTERGON - 3 - -
STREHLKE3 - - -
UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES2 - - -